Interference No. 104,101
Page 6
August 22-26. The rats were sacrificed and measurements including blood serum
cholesterol concentration were analyzed.
(EX 1156, ¶ 12).
F9. Mr. Magee did not testify as to the structure of the LY 125001 compound.
F10. Lilly has failed to sufficiently identify the structure of compound 125001. Additionally,
Lilly has failed to sufficiently identify evidence that an inventor or agent thereof appreciated that
the biological activity tests established the usefulness of compound 125001.
2. Lilly Compound 311583
F11. Lilly compound 311583 is said to have the following structure:
(EX 1216). The compound depicted above falls within the scope of Count 2, the sole count in
interference.
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007